NFKB1 and Insulin resistance: We suspect that apoAI-induced suppression of hepatic NF-κB activation is central to the overall protective effect of apoAI on insulin resistance, a suggestion consistent with the observations of Shoelson and colleagues, who demonstrated that NF-κB activation alone in the liver is sufficient to drive the onset of insulin resistance in mice (4).